Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 3 | +172 K | 100% | $3.86 | +$663 K |
Sells | 0 | ||||
Net | +3 | +172 K | 100% | +$663 K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Sergio Traversa | Chief Executive Officer, Director | $975 K | +$387 K | +65.7% | May 24, 2024 |
Chuck Ence | CA and CO | $158 K | +$151 K | +2127% | May 24, 2024 |
Maged Shenouda | Chief Financial Officer | $142 K | +$126 K | +779% | May 24, 2024 |
Cedric O'Gorman | Chief Medical Officer | $32.2 K | May 23, 2023 | ||
Fabiana Fedeli | Director | May 24, 2024 | |||
Charles J. Casamento | Director | May 24, 2024 | |||
Paul Kelly | Director | May 24, 2024 | |||
Eric Schmidt | Director | May 25, 2023 | |||
John Glasspool | Director | May 24, 2024 |
Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
---|